[Antithrombin III in the treatment of disseminated intravascular coagulation]. 1997

I Nordgaard-Andersen, and J R Madsen
Medicinsk gastroenterologisk afdeling 261, H:S Hvidovre Hospital.

UI MeSH Term Description Entries
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D019317 Evidence-Based Medicine An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006) Medicine, Evidence-Based,Evidence Based Medicine,Medicine, Evidence Based

Related Publications

I Nordgaard-Andersen, and J R Madsen
May 1989, Circulatory shock,
I Nordgaard-Andersen, and J R Madsen
April 1980, American journal of clinical pathology,
I Nordgaard-Andersen, and J R Madsen
April 1978, Lancet (London, England),
I Nordgaard-Andersen, and J R Madsen
June 1978, Lancet (London, England),
I Nordgaard-Andersen, and J R Madsen
January 1977, Folia haematologica (Leipzig, Germany : 1928),
I Nordgaard-Andersen, and J R Madsen
January 1985, The American journal of pediatric hematology/oncology,
I Nordgaard-Andersen, and J R Madsen
January 1983, Nephron,
I Nordgaard-Andersen, and J R Madsen
June 1982, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Nordgaard-Andersen, and J R Madsen
June 1988, Circulatory shock,
I Nordgaard-Andersen, and J R Madsen
January 1981, Acta medica Scandinavica,
Copied contents to your clipboard!